Skip to content

A CLINICAL TRIAL TO STUDY THE EFFECT OF PATHADI CHURNA IN FUNGAL INFECTION OF SKIN

AN OPEN LABEL DOUBLE ARM RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATHADI CHURNA IN DADRU(TINEA)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030238
Enrollment
54
Registered
2021-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: PATHADI CHURNA internally AND CHAKRAMARDA TAILA FOR LOCAL APPLICATION.: PATHADI CHURNA is an ayurvedic medicine having Sahastrayogam chokhamba sanskrit seriesoffice,varansi second editi

Sponsors

Dean Faculty of Ayurved Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical signs like kandu, raga, mandala, pidika. Patients of all varieties of Tinea will be included irrespective of area of infection. Viz., Tinea â??corporis, crusis, capitis, pedis, manuum, except tinea unguium, tinea barbae . Chronicity not more than 1 year.

Exclusion criteria

Exclusion criteria: patient having Tinea unginum, tinea barbae. K/C/o Uncontrolled Hypertension & Diabetes Melitus. Pregnant and lactating Women. k/c/o of immunocompromised subjects & autoimmune cases.

Design outcomes

Primary

MeasureTime frame
Effect on symptoms of dadru Effect on KOH Test in each group of 4 patientsTimepoint: Effect on symptoms of dadru at baseline and at the end of every 15 days till 60 days. Effect on KOH Test in each group of 4 patients at baseline and at the end of 60 days.

Secondary

MeasureTime frame
Itching (kandu) Inflammation (pidika) Color changes(raga) Nature of lesion (mandalas) Size of lesion(size of mandalas) No.of lesion (no.of mandalas) No.of lesions (no. of mandalas)1. 5-D Pruritus scale 2. Dermatology life quality index (DLQI). 3. Photographic evidence.Timepoint: Effect on symptoms at baseline and at the end of every 15 days till 60 days.

Countries

India

Contacts

Public ContactDr Drushti Narendrasinh Chauhan

Parul Institute of Ayurved

drushtichauhan17@gmail.com9426510026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026